Britanin – a beacon of hope against gastrointestinal tumors?

Figure 2 Novel research directions which could be adopted in future gastrointestinal research on Britanin. The light-yellow rectangles represent data on Britanin obtained from studies other than those associated with liver, colorectal, pancreatic, and gastric cancer. Processes included therein are linked to various tumor-related phenomena, which are depicted in gray rectangles. Britanin was not yet investigated in these tumor-related phenomena, which was marked with solid red arrows and question marks (“?”). Such information may suggest the direction of further research on gastrointestinal tumors.